GIC Private Limited sold 755,000 shares of HENGRUI PHARMA on the SEHK open market at an average of HKD 52.2285 per share on November 6, 2026, involving about HKD 39.43 million; this was an on-exchange active trade and a direct secondary-market dealing.
Prior to the disposal, GIC Private Limited’s long position in HENGRUI PHARMA was 30.99 million shares, representing 12.0%; following the disposal, the holding changed to 30.23 million shares, with the long position ratio falling to 11.71%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments